OREXIGEN Therapeutics - Ownership and Business Overview

Life ScienceCompany

OREXIGEN Therapeutics Ownership

Who owns OREXIGEN Therapeutics?

OREXIGEN Therapeutics is owned by Nalpropion Pharmaceuticals. It was acquired on April 24, 2018.

Was OREXIGEN Therapeutics formerly PE-backed?

Yes. OREXIGEN Therapeutics was formerly owned by 2 private investors.

OREXIGEN Therapeutics Business Overview

Where is OREXIGEN Therapeutics headquartered?

OREXIGEN Therapeutics is headquartered in La Jolla, California.

What is OREXIGEN Therapeutics’ revenue?

OREXIGEN Therapeutics disclosed revenue of 89M USD for 2017 and 34M USD for 2016.

How many employees does OREXIGEN Therapeutics have?

OREXIGEN Therapeutics has 47 employees.

What sector is OREXIGEN Therapeutics in?

OREXIGEN Therapeutics is a life science company.

When was OREXIGEN Therapeutics founded?

OREXIGEN Therapeutics was founded in 2002.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.

OREXIGEN Therapeutics, Inc.

3344 N. Torrey Pines Court, Suite 200,
La Jolla, California 92037
United States,
(858) 875-8600
www.orexigen.com

Orexigen Therapeutics, Inc. is a bio-pharmaceutical company focuses on the treatment of obesity. The Company's lead product candidate is Contrave, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA.


 Subscribe to unlock this and 201,688
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.